Find Technologies

  • Nucleic Acid-based Differentiation and Identification of Medically Important Fungi
    •
       Ref: E-332-2013-0 | Updated: Dec 23, 2013 | CDC
  • Nucleic Acid-based Compositions and Methods for the Detection of Pathogenic Candida or Aspergillus Fungi Species
    •
       Ref: E-339-2013-0 | Updated: Dec 23, 2013 | CDC
  • Improved Protein Quantification Process and Vaccine Quality Control Production
    •
       Ref: E-212-2013-0 | Updated: Dec 23, 2013 | CDC
  • Nucleic Acid-based Compositions and Methods for the Species-Specific Detection of Pathogenic Candida Fungi
    •
       Ref: E-340-2013-0 | Updated: Dec 23, 2013 | CDC
  • Novel Live-Attenuated Rabies Vaccine
    •
       Ref: E-326-2013-0 | Updated: Nov 15, 2013 | CDC
  • Method of Enhancing Opsonophagocytosis
    •
       Ref: E-329-2013-0 | Updated: May 07, 2018 | CDC
  • Real-time RT-PCR Assay For Detection and Quantification of Hepatitis D Virus Infection
    •
       Ref: E-510-2013-0 | Updated: May 22, 2014 | CDC
  • Peptide Vaccines Against Group A Streptococci
    •
       Ref: E-330-2013-0 | Updated: Oct 23, 2013 | CDC
  • Novel Targets to Prevent Borrelia burgdorferi Infection and Lyme Disease
    •
       Ref: E-573-2013-0 | Updated: Feb 10, 2014 | CDC
  • Aortic Access from Vena Cava for Large Caliber Transcatheter Cardiovascular Interventions
    •
       Ref: E-553-2013-0 | Updated: Sep 10, 2013 | NHLBI
  • Dipicolylamine-based Nanoparticles for Delivery of Ligands
    •
       Ref: E-066-2012-0 | Updated: Sep 17, 2015 | NIBIB
  • Monoclonal Antibodies that Neutralize Norovirus
    •
       Ref: E-226-2011-0 | Updated: Jul 06, 2020 | NIAID
  • sodC-Based Real-Time PCR Assay for Detection of Neisseria meningitidis Infection
    •
       Ref: E-165-2013-0 | Updated: Sep 17, 2013 | CDC
  • Isolated Lyssavirus Nucleic Acid and Protein Sequences
    •
       Ref: E-179-2013-0 | Updated: Sep 17, 2013 | CDC
  • Antigen-capture Electrochemiluminescent Assay for Determining Rabies Vaccine Potency
    •
       Ref: E-180-2013-0 | Updated: Sep 17, 2013 | CDC
  • Real-time PCR Assays for Selective Detection and Differentiation of B. pertussis, B. parapertussis and B. homesii
    •
       Ref: E-193-2013-0 | Updated: Sep 17, 2013 | CDC
  • Recombinant Pan-Lyssavirus for Use in Rabies and Broad-Lyssavirus Vaccination
    •
       Ref: E-256-2013-0 | Updated: Sep 17, 2013 | CDC
  • Methods of Detecting and Identifying Both Known and Novel Influenza Viruses
    •
       Ref: E-274-2013-0 | Updated: Sep 18, 2013 | CDC
  • Novel Recombinant Rabies Vaccine Also Capable of Immunocontraception
    •
       Ref: E-298-2013-0 | Updated: Sep 19, 2013 | CDC
  • Real-time PCR Multiplex Assay for Detection of Bacterial Respiratory Pathogens in Clinical Specimens
    •
       Ref: E-300-2013-0 | Updated: Sep 19, 2013 | CDC
  • Nucleic Acid Amplification Technique for Rapid Diagnostic Analysis
    •
       Ref: E-273-2013-0 | Updated: Mar 09, 2020 | CDC
  • Monoclonal Antibodies That Recognize the Human Type I Interferon Receptor and Block Interferon Signaling
    •
       Ref: E-527-2013-0 | Updated: Aug 22, 2013 | NIAID
  • Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology
    •
       Ref: E-120-2013-0 | Updated: Oct 02, 2017 | NIAID
  • Composition and Methods for Rapid Detection of HIV by Loop-mediated Isothermal Amplification
    •
       Ref: E-173-2013-0 | Updated: Nov 20, 2013 | CDC
  • Reduced Virulence Crimean-Congo Hemorrhagic Fever Virus for Vaccine Development
    •
       Ref: E-486-2013-0 | Updated: Aug 23, 2013 | CDC
  • Fluorescent Primer(s) Creation for Nucleic Acid Detection and Amplification
    •
       Ref: E-252-2013-0 | Updated: Mar 09, 2020 | CDC
  • Nucleic Acid Primers and Probes for Detecting Ebola Virus (species Zaire ebolavirus)
    •
       Ref: E-056-2015-0 | Updated: Sep 15, 2017 | CDC
  • Novel Fourth Human Ebolavirus species, Bundibugyo ebolavirus – Compositions and Methods for Vaccine, Therapeutics and Highly Sensitive Diagnostic Assay Development
    •
       Ref: E-159-2013-0 | Updated: Jun 07, 2018 | CDC
  • Monitoring Public Water Supply for a Variety of Pathogens
    •
       Ref: E-458-2013-0 | Updated: Mar 09, 2020 | CDC
  • Live Attenuated RSV Vaccines Based on Codon-Pair Deoptimization
    •
       Ref: E-080-2013-0 | Updated: Jun 06, 2013 | NIAID
  • Engineered Anthrax Toxin Variants that Target Cancer
    •
       Ref: E-246-2012-0 | Updated: Jul 06, 2017 | NIDCR
  • Intra-bone Drug Delivery Device and Method
    •
       Ref: E-165-2012-0 | Updated: Feb 19, 2015 | NHLBI
  • Islet Beta Cell Only M3 Muscarinic Acetylcholine Receptor Knockout Mouse
    •
       Ref: E-452-2013-0 | Updated: Apr 18, 2017 | NIDDK
  • Transgenic Mice with Constitutively Active M3 Muscarinic Receptor in Islet Beta Cells
    •
       Ref: E-453-2013-0 | Updated: Mar 24, 2017 | NIDDK
  • Transgenic Mice Overexpressing Islet Beta Cell M3 Muscarinic Acetylcholine Receptors
    •
       Ref: E-455-2013-0 | Updated: Apr 18, 2017 | NIDDK
  • Simultaneous Detection of Non-pneumophila Legionella Strains Using Real-time PCR
    •
       Ref: E-277-2013-0 | Updated: Aug 02, 2013 | CDC
  • Real-Time RT-PCR Assay for Detection of Noroviruses
    •
       Ref: E-145-2013-0 | Updated: Aug 02, 2013 | CDC
  • Multiplex Assay for Detection of Dengue Virus
    •
       Ref: E-148-2013-0 | Updated: Oct 18, 2013 | CDC
  • Rabbit Antibody to Mouse Sphingosine-1-phosphate (S1P) lyase
    •
       Ref: E-465-2013-0 | Updated: Aug 06, 2013 | NIDDK
  • Rabbit Antibody to Mouse Sphingosine kinase 2 (SphK2)
    •
       Ref: E-466-2013-0 | Updated: Aug 06, 2013 | NIDDK
  • Cotranslational Protein Expression System for High-throughput Screening
    •
       Ref: E-300-2012-0 | Updated: Nov 18, 2015 | NCATS
  • Rapid Detection of Multi-Drug-Resistant Mycobacterium tuberculosis Using Real-Time PCR and High-Resolution Melt Analysis
    •
       Ref: E-160-2013-0 | Updated: Dec 05, 2013 | CDC
  • Real-time TaqMan RT-PCR Assays for Selective Detection of Human Rhinovirus
    •
       Ref: E-177-2013-0 | Updated: Aug 13, 2013 | CDC
  • Real-Time PCR for Detecting Legionella Species and Discriminating Legionella pneumophila
    •
       Ref: E-194-2013-0 | Updated: Sep 19, 2013 | CDC
  • Software to Improve the Quality of Microscopy Images
    •
       Ref: E-062-2013-0 | Updated: Feb 21, 2013 | NIBIB
  • Highly Potent and Selective Deubiquitinating Enzyme Inhibitor
    •
       Ref: E-043-2013-0 | Updated: Nov 18, 2015 | NCATS
  • User-friendly, Powerful Software for Analyzing ChIP-Seq Data
    •
       Ref: E-008-2012-0 | Updated: Apr 23, 2013 | NIAMS
  • Magnetic Resonance Arterial Wall Imaging Methods that Compensate for Patient Aperiodic Intrinsic Cardiac, Chest Wall, and Blood Flow-Induced Motions
    •
       Ref: E-185-2012-0 | Updated: Oct 22, 2012 | NIDDK
  • Cyclodextrins as Therapeutics for Lysosomal Storage Disorders
    •
       Ref: E-050-2012-0 | Updated: Nov 18, 2015 | NCATS
  • Novel Small Molecule Agonists of the Relaxin Receptor as Potential Therapy for Heart Failure and Fibrosis
    •
       Ref: E-072-2012-0 | Updated: Nov 18, 2015 | NCATS
  • Small Molecule MRS5474 with Anticonvulsant Activity for Treatment of Epilepsy
    •
       Ref: E-285-2008-1 | Updated: Aug 31, 2016 | NIDDK
  • Glucocorticoid-induced TNFR Family-Related Receptor Ligand (GITRL) Antibodies for Diagnosis and Treatment of Immune System Disorders
    •
       Ref: E-229-2003-2 | Updated: Nov 16, 2012 | NIAID
  • Axon Regeneration After Brain or Spinal Cord Injury
    •
       Ref: E-214-2012-0 | Updated: Nov 21, 2012 | NHLBI
  • Methods and Composition for Identification of Variants of JC Virus DNA; An Etiologic Agent for Progressive Multifocal Leukoencephalopathy (PML)
    •
       Ref: E-088-2012-0 | Updated: Jan 11, 2013 | NINDS
  • A3 Adenosine Receptor Agonists to Treat Chemotherapy-induced Peripheral Neuropathy
    •
       Ref: E-140-2008-1 | Updated: Jun 13, 2012 | NIDDK
  • Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin as an Influenza Vaccine
    •
       Ref: E-293-2011-0 | Updated: Aug 03, 2020 | NIAID
  • Polyclonal Antibodies for the Specialized Signaling G protein, Gbeta5
    •
       Ref: E-192-2006-0 | Updated: Jul 27, 2012 | NIDDK
  • Plasmid Useful in Transplantation Therapy for Age-Related Eye Disease
    •
       Ref: E-054-2012-0 | Updated: Aug 10, 2012 | NINDS
  • Image Analysis Software for Quantitative Evaluation of Striation Patterns and their Defects in Skeletal Muscles
    •
       Ref: E-264-2012-0 | Updated: Sep 10, 2012 | NIAMS
  • Capillary Viscometer for Measuring Viscosity of Macromolecular Solutions of Biological Relevance
    •
       Ref: E-231-2012-0 | Updated: Sep 06, 2016 | NIDDK
  • New Targeted Therapy for Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
    •
       Ref: E-060-2011-0 | Updated: Sep 10, 2012 | NHGRI
  • A Method to Expand a Population of Regulatory T Cells Optimal for the Treatment of Autoimmune Diseases
    •
       Ref: E-279-2011-0 | Updated: Sep 09, 2015 | NIAID
  • Gs Alpha LoxP (Gnastm1Lsw) Mouse Model for Metabolism Studies
    •
       Ref: E-117-2012-0 | Updated: Feb 12, 2015 | NIDDK
  • Alb-tTA (Tg(Alb1-tTA)3123Lng) Mouse Model for Liver Function Studies
    •
       Ref: E-125-2012-0 | Updated: Apr 18, 2017 | NIDDK
  • MUP-tTA Mouse Model for Liver Function Studies
    •
       Ref: E-126-2012-0 | Updated: Apr 17, 2017 | NIDDK
  • Broadly Neutralizing Human Anti-HIV Monoclonal Antibody 10E8 and Related Antibodies Capable of Neutralizing Most HIV-1 Strains
    •
       Ref: E-253-2011-0 | Updated: Jun 18, 2014 | NIAID
  • Hspa2 Knockout Mice for Study of Spermatogenesis and Male Infertility
    •
       Ref: E-052-2011-0 | Updated: Sep 04, 2020 | NIEHS
  • Transgenic Hspa2-Cre Mice for Studying Spermatogenesis and Male Infertility
    •
       Ref: E-290-2011-0 | Updated: Sep 04, 2020 | NIEHS
  • Java Applet for Modeling Human Metabolism and Energy Expenditure for Adaptive Dieting and Exercise Regimens
    •
       Ref: E-160-2012-0 | Updated: May 03, 2013 | NIDDK
  • Antagonist of A3 Adenosine Receptor Fluorescent Probes for the Study of Diseases that Involve A3 Signaling
    •
       Ref: E-073-2012-0 | Updated: Feb 18, 2016 | NIDDK
  • GLI-Similar 3(GLIS3) Knock Out (KO) Mice as Models to Screen Therapeutics for Diabetes, Polycystic Kidney Disease, and Hypothyroidism
    •
       Ref: E-303-2011-0 | Updated: Sep 04, 2020 | NIEHS
  • M3 Muscarinic Receptor Knockout Mice (Chrm3 tm1Jwe) for the Study of Obesity and Other Metabolic Disorders
    •
       Ref: E-346-2004-2 | Updated: Apr 17, 2017 | NIDDK
  • Treatment of Viral Infection by Blocking Interleukin-21
    •
       Ref: E-017-2012-0 | Updated: Jun 06, 2012 | NHLBI
  • Endothelial Cell Line to Study Prevention of Atherosclerosis
    •
       Ref: E-149-2012-0 | Updated: Jun 13, 2012 | NHLBI
  • Mouse Model of STAT5 for the Drug Screen and the Research of Cancer and Autoimmunity
    •
       Ref: E-080-2011-0 | Updated: Jun 13, 2012 | NHLBI
  • Fast Acting Molecular Probes for Real-Time In Vivo Study of Disease and Therapeutics
    •
       Ref: E-079-2011-0 | Updated: Feb 12, 2015 | NIBIB
  • Diagnostic Test and Therapeutic Target for Sjogren's Syndrome
    •
       Ref: E-232-2011-0 | Updated: Apr 06, 2017 | NIDCR
  • Potential Use of anti-IgE in the Treatment of Lupus Nephritis
    •
       Ref: E-216-2010-0 | Updated: Mar 27, 2012 | NIAMS
  • mEpoR Knockout/Tg(hEpoR) Mouse Model for Anemia and Renal Function Studies
    •
       Ref: E-127-2001-0 | Updated: Feb 12, 2015 | NIDDK
  • M5 Muscarinic Receptor Knockout (Chrm5tm1Jwe) Mouse Model for Neurological Studies
    •
       Ref: E-110-2012-0 | Updated: Apr 17, 2017 | NIDDK
  • Stat1LoxP (Stat1 tm1Mam ) Mouse Model for Oncology and Immunology Studies
    •
       Ref: E-111-2012-0 | Updated: Mar 10, 2014 | NIDDK
  • Tg(Wap-cre)11738Mam Mouse Model for Developmental Biology Studies
    •
       Ref: E-112-2012-0 | Updated: Apr 19, 2012 | NIDDK
  • Tg(MMTV-Cre)#Mam Mouse Model for Developmental Biology, Hepatology, and Oncology Studies
    •
       Ref: E-113-2012-0 | Updated: Apr 17, 2017 | NIDDK
  • Stat5a LoxP/Stat5b LoxP (Stat5a/Stat5btm2Mam) Mouse Model for Mammopoietic and Lactogenic Signaling Studies
    •
       Ref: E-114-2012-0 | Updated: Feb 12, 2015 | NIDDK
  • Bcl-x LoxP (Bcl2l1 tm1.1Mam) Mouse Model for Developmental Biology Studies
    •
       Ref: E-115-2012-0 | Updated: Mar 10, 2014 | NIDDK
  • Stat5a Knockout (Stat5atm1Mam) Mouse Model for Mammopoietic and Lactogenic Signaling Studies
    •
       Ref: E-116-2012-0 | Updated: Feb 12, 2015 | NIDDK
  • AAV Mediated CTLA-4 Gene Transfer to Treat Sjogren's Syndrome
    •
       Ref: E-087-2011-0 | Updated: Nov 18, 2011 | NIDCR
  • New Cholera Vaccine and Method for Conjugating Bacterial Polysaccharides to Proteins
    •
       Ref: E-234-2011-0 | Updated: Jul 12, 2017 | NIDDK
  • Modulating Autophagy as a Treatment for Lysosomal Storage Diseases
    •
       Ref: E-210-2009-0 | Updated: Jan 17, 2012 | NIAMS
  • Transgenic Human Interleukin-21 Mouse Model
    •
       Ref: E-231-2010-0 | Updated: Jan 18, 2012 | NHLBI
  • Model Cell Lines With and Without AKT1 Mutations Derived from Proteus Syndrome Patients
    •
       Ref: E-033-2012-0 | Updated: Oct 13, 2015 | NHGRI
  • Platform Technology Using Ubiquitin to Improve the Delivery and Efficacy of Cytosolic Targeted Toxins
    •
       Ref: E-150-2011-0 | Updated: Sep 29, 2011 | NIDCR
  • mGluR5 Tumor Mouse Model
    •
       Ref: E-123-2010-0 | Updated: Sep 29, 2011 | NINDS
  • Human Phospho-Serine134 Glucocorticoid Receptor Polyclonal Antibody: Useful for the Characterization of Glucocorticoid Signaling Processes, e.g., in Cancer and Inflammation
    •
       Ref: E-182-2011-0 | Updated: Sep 04, 2020 | NIEHS
  • Protease Deficient Bacillus anthracis with Improved Recombinant Protein Yield Capabilities
    •
       Ref: E-202-2011-0 | Updated: Feb 25, 2015 | NIAID
  • TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS
    •
       Ref: E-213-2015-0 | Updated: Nov 20, 2020 | NIDDK
  • Hybridoma C4H3, Monoclonal Antibody to a Specific Peptide-MHC Class II Complex
    •
       Ref: E-021-2008-0 | Updated: Sep 19, 2017 | NIAID
  • New Molecules for HIV Therapeutics: Fab, scFv, and Related Binding Molecules Specific for HIV-1 Rev
    •
       Ref: E-064-2011-0 | Updated: May 09, 2018 | NIAMS
  • Glucocerebrosidase Activators as a Treatment for Gaucher Disease
    •
       Ref: E-257-2010-0 | Updated: Oct 06, 2011 | NCATS
  • Mouse Model for Cerebral Cavernous Malformation, an Inherited Brain Disorder
    •
       Ref: E-158-2011-0 | Updated: Jun 15, 2011 | NHLBI

    Pages


    Displaying 401 - 500 of 1378

    Category Index

    Office of Technology Transfer, Office of Intramural Research, National Institutes of Health

    6011 Executive Blvd, Suite 325, Rockville, MD 20852 | Phone: 301-496-7057